AKTX vs LYV · $17.2M cap vs P/E 49, rev $11.46B
Akari Therapeutics PLC (AKTX) versus Live Nation Entertainment Inc (LYV) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported LYV revenue for 2026-06-30 was $11.46B. Net income was -$94.7M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
AKTX currently screens at market cap $17.2M. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Not investment advice. Open the AKTX and LYV stock pages for the full models.
Not investment advice.